Kim, Myong <br/><br/>
Prognostic value of vascular endothelial growth factor (VEGF), VEGF receptor 2, platelet-derived growth factor-β (PDGF-β), and PDGF-β receptor expression in papillary renal cell carcinoma.  [electronic resource] 

 -  Human pathology  03 2017 
 - 78-89 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1532-8392 
<br/><br/><label>Standard No.: </label>10.1016/j.humpath.2016.12.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Angiogenesis Inhibitors--therapeutic use<br/>Biomarkers, Tumor--analysis<br/>Biopsy<br/>Carcinoma, Renal Cell--chemistry<br/>Chemotherapy, Adjuvant<br/>Chi-Square Distribution<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Kaplan-Meier Estimate<br/>Kidney Neoplasms--chemistry<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Molecular Targeted Therapy<br/>Multivariate Analysis<br/>Nephrectomy<br/>Proportional Hazards Models<br/>Proto-Oncogene Proteins c-sis--analysis<br/>Receptor, Platelet-Derived Growth Factor beta--analysis<br/>Retrospective Studies<br/>Time Factors<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor A--analysis<br/>Vascular Endothelial Growth Factor Receptor-2--analysis